T1	Participants 84 99	prostate cancer
T2	Participants 305 352	patients with clinically organ-confined disease
T3	Participants 794 838	limit status in patients with prostate cance
T4	Participants 963 991	259 men with prostate cancer
T5	Participants 2760 2785	men with clinical stage B
